When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Agile Therapeutics
The Trade: Agile Therapeutics Inc (NASDAQ:AGRX) CEO Al Altomari acquired a total of 26200 shares shares at an average price of $1.26. The insider spent $33,095.84 to buy those shares.
What’s Happening: Agile Therapeutics recently reported better-than-expected Q2 earnings.
What Agile Therapeutics Does: Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women.
Minim
The Trade: Minim, Inc. (NASDAQ:MINM) CEO Graham Chynoweth acquired a total of 200000 shares shares at an average price of $2.50. The insider spent $500,000.00 to buy those shares.
What’s Happening: Minim reported pricing of a $25 million public offering of common stock.
What Minim Does: Minim Inc is the creator of innovative internet access products that dependably connect people to the they need and the people they love.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
